Adding rigor to stroke risk prediction in atrial fibrillation

Journal of the American College of Cardiology

Volumn 65, Issue 3, 2015, Pages 233-235

  Singer, Daniel E ^a   Ezekowitz, Michael D ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

anticoagulation; atrial fibrillation; risk scores; stroke prevention

Indexed keywords

ANTICOAGULANT AGENT;

AGE; ANTICOAGULANT THERAPY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; HEART ATRIUM FIBRILLATION; HUMAN; LOW RISK PATIENT; MEDICAL SOCIETY; NOTE; PRACTICE GUIDELINE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRANSIENT ISCHEMIC ATTACK; ATRIAL FIBRILLATION; FEMALE; MALE; STROKE;

ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; RISK ASSESSMENT; STROKE;

EID: 84921405542     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.11.013     Document Type: Editorial

References (13)

1. C.T. January, L.S. Wann, and J.S. Alpert 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 e1 e76
2. A.J. Camm, G.Y. Lip, and R. De Caterina 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
3. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
4. J.P. Piccini, and D.E. Singer Putting risk prediction in AF into perspective Eur Heart J 33 2012 1431 1433
5. 2 -VASc score of 1 J Am Coll Cardiol 65 2015 225 232
6. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
7. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
8. D.E. Singer, Y. Chang, and L.H. Borowsky A new risk score to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA Study Stroke Risk Score J Am Heart Assoc 2 2013 e000250
9. L. Friberg, M. Rosenqvist, and G.Y. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study Eur Heart J 33 2012 1500 1510
10. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
11. M.H. Eckman, D.E. Singer, J. Rosand, and S.M. Greenberg Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation Circ Cardiovasc Qual Outcomes 4 2011 14 21
12. S. Koton, A.L. Schneider, and W.D. Rosamond Stroke incidence and mortality trends in US communities, 1987 to 2011 JAMA 312 2014 259 268
13. D.E. Singer, Y. Chang, and M.C. Fang The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305